Division of Surgical Oncology, Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences.
Department of Human Genetics, Nagasaki University Graduate School of Biomedical Sciences , 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Acta Histochem Cytochem. 2014 Jun 28;47(3):85-94. doi: 10.1267/ahc.13040. Epub 2014 Jun 18.
ATP-binding cassette (ABC) transporters are involved in chemotherapy resistance. Multidrug-resistance protein 8 (ABCC11/MRP8) is also involved in 5-fluorouracil (5-FU) metabolism. 5-FU and its derivatives are widely used in the treatment of gastrointestinal tract cancers, but little is known about the contribution of ABCC11/MRP8 to gastrointestinal tract and related cancers. Here, we report our investigation of ABCC11/MRP8 expression in normal and cancerous gastrointestinal tract tissues and reveal its novel role in the gastric mucosa. In tissue microarray and surgically resected cancer specimens, immunohistochemical (IHC) staining revealed significantly reduced expression of ABCC11/MRP8 in gastrointestinal tract cancers compared with other cancers. In contrast, strong ABCC11/MRP8 expression was observed in normal gastric mucosa. Additional immuno-fluorescence assays revealed co-localization of ABCC11/MRP8 and pepsinogen I in normal gastric chief cells. Quantitative PCR and Western blot analysis also revealed significant expression of ABCC11/MRP8 in fundic mucosa where the chief cells are mainly located. Furthermore, the ABCC11 mRNA-suppressed NCI-N87 gastric cancer cell line failed to secret pepsinogen I extracellularly. Thus, low expression of ABCC11/MRP8 is consistent with chemotherapeutic regimens using 5-FU and its derivatives in gastrointestinal tract cancers. Our results indicated a novel function of ABCC11/MRP8 in the regulation of pepsinogen I secretion in the normal gastric chief cells.
三磷酸腺苷结合盒(ABC)转运蛋白参与化疗耐药。多药耐药蛋白 8(ABCC11/MRP8)也参与 5-氟尿嘧啶(5-FU)代谢。5-FU 及其衍生物广泛用于胃肠道癌症的治疗,但 ABCC11/MRP8 对胃肠道和相关癌症的贡献知之甚少。在这里,我们报告了我们对 ABCC11/MRP8 在正常和癌胃肠道组织中的表达的研究,并揭示了它在胃黏膜中的新作用。在组织微阵列和手术切除的癌症标本中,免疫组织化学(IHC)染色显示 ABCC11/MRP8 在胃肠道癌症中的表达明显低于其他癌症。相比之下,正常胃黏膜中观察到强烈的 ABCC11/MRP8 表达。额外的免疫荧光检测显示 ABCC11/MRP8 与胃蛋白酶原 I 在正常胃主细胞中的共定位。定量 PCR 和 Western blot 分析也显示 ABCC11/MRP8 在胃底黏膜中表达显著,而主细胞主要位于胃底黏膜中。此外,ABCC11 mRNA 抑制的 NCI-N87 胃癌细胞系无法将胃蛋白酶原 I 分泌到细胞外。因此,ABCC11/MRP8 的低表达与胃肠道癌症中使用 5-FU 及其衍生物的化疗方案一致。我们的结果表明 ABCC11/MRP8 在正常胃主细胞中调节胃蛋白酶原 I 分泌的新功能。